• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人及大鼠2型11β-羟类固醇脱氢酶的氧化还原酶和脱氢酶活性

Oxoreductase and dehydrogenase activities of the human and rat 11beta-hydroxysteroid dehydrogenase type 2 enzyme.

作者信息

Li K X, Obeyesekere V R, Krozowski Z S, Ferrari P

机构信息

Laboratory of Molecular Hypertension, Baker Institute of Medical 1esearch, Prahran, Victoria, Australia.

出版信息

Endocrinology. 1997 Jul;138(7):2948-52. doi: 10.1210/endo.138.7.5232.

DOI:10.1210/endo.138.7.5232
PMID:9202239
Abstract

The 11beta-hydroxysteroid dehydrogenase type 2 enzyme (11betaHSD2) metabolizes glucocorticoids into their inactive 11-keto metabolites. Although the type 1 enzyme (11betaHSD1) displays both oxidative and reductive activity, to date 11betaHSD2 has been shown to have dehydrogenase activity only. In this study we compared both dehydrogenase and reductase characteristics of the cloned rat 11betaHSD1 and rat and human 11betaHSD2 for three different 11-hydroxysteroid substrates, cortisol (F), corticosterone (B), and dexamethasone (Dex), and the corresponding 11-keto metabolites, cortisone (E), 11-dehydrocorticosterone (A), and 11-dehydrodexamethasone (DH-Dex), respectively. In cell homogenates expressing either the rat or the human 11betaHSD2, the relative potency for the dehydrogenase reaction was B > F > Dex. Although there was no reduction of A or E, DH-Dex was readily converted to Dex with an equilibrium far on the side of the 11-hydroxy metabolite. DH-Dex reduction in homogenates was inhibited by both glycyrrhetinic acid and carbenoxolone, with a 50% inhibition at 80 and 100 nM, respectively. In intact cells transfected with rat 11betaHSD1, the equilibrium was on the reductase side for all substrates. Dehydrogenation of B or F was more potent with rat 11betaHSD2 than with rat 11betaHSD1. There was no detectable 11betaHSD1 oxidation of Dex. These data indicate that both the cloned human and rat 11betaHSD2 reduce DH-Dex and do this more readily than they oxidize Dex. Thus, 11betaHSD2 seems also to be a bidirectional enzyme, although no reduction of the physiological compounds A and E was observed.

摘要

2型11β-羟基类固醇脱氢酶(11βHSD2)可将糖皮质激素代谢为无活性的11-酮代谢产物。虽然1型酶(11βHSD1)兼具氧化和还原活性,但迄今为止,11βHSD2仅表现出脱氢酶活性。在本研究中,我们比较了克隆的大鼠11βHSD1以及大鼠和人类11βHSD2对三种不同的11-羟基类固醇底物(皮质醇(F)、皮质酮(B)和地塞米松(Dex))以及相应的11-酮代谢产物(可的松(E)、11-脱氢皮质酮(A)和11-脱氢地塞米松(DH-Dex))的脱氢酶和还原酶特性。在表达大鼠或人类11βHSD2的细胞匀浆中,脱氢酶反应的相对效力为B>F>Dex。虽然未观察到A或E的还原,但DH-Dex很容易转化为Dex,且平衡状态远偏向11-羟基代谢产物一侧。匀浆中DH-Dex的还原受到甘草次酸和甘珀酸的抑制,其半数抑制浓度分别为80 nM和100 nM。在转染了大鼠11βHSD1的完整细胞中,所有底物的平衡均偏向还原酶一侧。大鼠11βHSD2对B或F的脱氢作用比大鼠11βHSD1更强。未检测到Dex的11βHSD1氧化作用。这些数据表明,克隆的人类和大鼠11βHSD2均可还原DH-Dex,且还原作用比氧化Dex更易发生。因此,11βHSD2似乎也是一种双向酶,尽管未观察到生理化合物A和E的还原。

相似文献

1
Oxoreductase and dehydrogenase activities of the human and rat 11beta-hydroxysteroid dehydrogenase type 2 enzyme.人及大鼠2型11β-羟类固醇脱氢酶的氧化还原酶和脱氢酶活性
Endocrinology. 1997 Jul;138(7):2948-52. doi: 10.1210/endo.138.7.5232.
2
Metabolism of dexamethasone in the human kidney: nicotinamide adenine dinucleotide-dependent 11beta-reduction.地塞米松在人肾脏中的代谢:烟酰胺腺嘌呤二核苷酸依赖性11β-还原反应
J Clin Endocrinol Metab. 1997 May;82(5):1598-602. doi: 10.1210/jcem.82.5.3936.
3
Truncation of the N- and C-terminal regions of the human 11beta-hydroxysteroid dehydrogenase type 2 enzyme and effects on solubility and bidirectional enzyme activity.人2型11β-羟基类固醇脱氢酶N端和C端区域的截短及其对溶解性和双向酶活性的影响。
Mol Cell Endocrinol. 1997 Aug 8;131(2):173-82. doi: 10.1016/s0303-7207(97)00106-8.
4
Substrate and inhibitor specificity of the cloned human 11 beta-hydroxysteroid dehydrogenase type 2 isoform.克隆的人2型11β-羟基类固醇脱氢酶同工型的底物和抑制剂特异性
Am J Physiol. 1996 May;270(5 Pt 1):E900-4. doi: 10.1152/ajpendo.1996.270.5.E900.
5
11beta-Hydroxysteroid dehydrogenase types 1 and 2 are up- and downregulated in cortisol-secreting adrenal adenomas.11β-羟类固醇脱氢酶1型和2型在分泌皮质醇的肾上腺腺瘤中上调和下调。
J Investig Med. 2002 Jul;50(4):288-92. doi: 10.2310/6650.2002.33012.
6
Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies.生长激素和胰岛素样生长因子对11β-羟基类固醇脱氢酶同工酶的调节:体内和体外研究
J Clin Endocrinol Metab. 1999 Nov;84(11):4172-7. doi: 10.1210/jcem.84.11.6108.
7
11beta-Hydroxysteroid dehydrogenase expression and activities in bovine granulosa cells and corpora lutea implicate corticosteroids in bovine ovarian physiology.11β-羟基类固醇脱氢酶在牛颗粒细胞和黄体中的表达及活性表明皮质类固醇参与牛的卵巢生理过程。
J Endocrinol. 2007 May;193(2):299-310. doi: 10.1677/joe.1.07025.
8
Isoforms of 11beta-hydroxysteroid dehydrogenase in human granulosa-lutein cells.
Mol Cell Endocrinol. 1997 Sep 19;132(1-2):43-52. doi: 10.1016/s0303-7207(97)00118-4.
9
11 beta-Hydroxysteroid dehydrogenase type 2 complementary deoxyribonucleic acid stably transfected into Chinese hamster ovary cells: specific inhibition by 11 alpha-hydroxyprogesterone.稳定转染至中国仓鼠卵巢细胞中的2型11β-羟基类固醇脱氢酶互补脱氧核糖核酸:11α-羟基孕酮的特异性抑制作用
Endocrinology. 1996 Jun;137(6):2308-14. doi: 10.1210/endo.137.6.8641180.
10
Distinguishing the activities of 11beta-hydroxysteroid dehydrogenases in vivo using isotopically labeled cortisol.使用同位素标记的皮质醇在体内区分11β-羟基类固醇脱氢酶的活性。
J Clin Endocrinol Metab. 2002 Jan;87(1):277-85. doi: 10.1210/jcem.87.1.8157.

引用本文的文献

1
Physiologically Based Pharmacokinetic Modeling: The Reversible Metabolism and Tissue-Specific Partitioning of Methylprednisolone and Methylprednisone in Rats.基于生理的药代动力学建模:大鼠体内甲基泼尼松龙和甲基泼尼松的可逆代谢及组织特异性分配
Drug Metab Dispos. 2024 Jun 17;52(7):662-672. doi: 10.1124/dmd.124.001711.
2
Glucocorticoids enhance CD163 expression in placental Hofbauer cells.糖皮质激素增强胎盘组织中Hofbauer 细胞的 CD163 表达。
Endocrinology. 2013 Jan;154(1):471-82. doi: 10.1210/en.2012-1575. Epub 2012 Nov 9.
3
The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.
人类类固醇生成及其疾病的分子生物学、生物化学和生理学。
Endocr Rev. 2011 Feb;32(1):81-151. doi: 10.1210/er.2010-0013. Epub 2010 Nov 4.
4
Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.心血管疾病中糖皮质激素代谢的治疗性调控
Br J Pharmacol. 2009 Mar;156(5):689-712. doi: 10.1111/j.1476-5381.2008.00047.x. Epub 2009 Feb 23.